← Eichor
Condition: Non Neoplastic Condition Nos Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Non Neoplastic Condition Nos

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myel
Phase N/A · 2 location(s) · MPN Research Foundation · NCT07362225Impact of Dietary Fiber Supplementation on Colonic Microbiome
NA · 1 location(s) · OHSU Knight Cancer Institute · NCT05643859Activation of Biobank Registry for Bilio-pancreatic Diseases
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06552078ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
NA · 1 location(s) · Hua-Jay J Cherng, MD · NCT06693830Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
Phase N/A · 1 location(s) · University of Washington · NCT06295965Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · 280 location(s) · Alliance for Clinical Trials in Oncology · NCT07091617ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Phase N/A · 71 location(s) · American Thrombosis and Hemostasis Network · NCT04398628Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders
Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT03980769
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.